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This report is a summary to date of a study of treatment-resistant syphilis
begun by one of us (H. B.) in 1932 and reviewed in 1936 (1) and 1938 (2). The
background of this perplexing problem has been fully described in our earlier
papers as well as in the recent publications of Netherton (3) and Beckh and
Kulchar (4). For purposes of orientation a statement of the current concepts
of the cause of treatment-resistant syphilis will be briefly reviewed. This will
be followed by an analysis of the results of our studies in rabbits of a strain of
Spirochaeta pallida isolated from a treatment-resistant paitent in 1932.
The consensus in the literature places the cause of the failure of a patient
with syphilis to respond to the usually effective antisyphilitic therapy on one
factor or a combination of three factors: the peculiarities of the host; the potency
of the drug; and a special biologic peculiarity in the strain of Spirochaeta paillida
Numerous proposals have been advanced to account for the role of these
factors in the production of treatment-resistant syphilis. Among them are:
Host (a) Deprivations of war. (b) Various factors including racial, physical,
and climatic. (c) Changed metabolism of the body with regard to the drug.
(d) Changes of drug into a form to which parasite is immune. (e) Failure of
"defensive" powers. (f) Host "accustomed" to drug. (g) Failure of certain
body cells (blood, lymphoid, reticuloendothelial). (h) Similarity of the course
of the disease in conjugal infections is determined by similarity of the hosts.
(i) Disorders of the endocrine glands. (j) Indirect evidence—changed treat-
ment leads to return of sensitiveness to drug, e.g., bismuth in arsphenamine re-
sistance. (k) Hepatic insufficiency. (1) Toxin theory. (m) Patients with
treatment-resistant syphilis often show signs of intolerance to the drug (reaction).
Netherton (3) concluded from his recent study that the host was the basis of
treatment-resistance. Resistance to both arsenic and the heavy metals tends,
in his opinion, to invalidate the possibility of an arsphenamine-resistant strain
of Spirochaeta pallida.
1 Contribution from the Abbott Fellowship in Chemotherapeutic Research.
2 From the Department of Dermatology and Syphilology, School of Medicine of the
University of Pennsylvania, and the Institute for the Control of Syphilis, John H. Stokes,
M. D., Director, and the Dermatological Research Laboratories, Division of the Abbott
Laboratories, North Chicago, Illinois.
The authors wish to thank Dr. George W. Raiziss whose cooperation as Director of the
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Drug (a) Quality of the drug has changed. (b) Intrinsic ineffectiveness of
a given formula. (c) Brands of drug vary. Lots of same brand vary. (d)
Differences in dosage and method of administration. Beckh and Kulchar (4)
believed there was little evidence to indicate definitely that the host and parasite
were at the bottom of treatment-resistant syphilis but felt, from their experience
with 18 cases resistant to three different arsenicals, including mapharsen, that
more cases occurred after combined (simultaneous or concurrent) than after an
alternating plan of treatment. We believe that this may have been due to
chronic underdosage in combined treatment necessary to avoid reactions.
Spirochete (a) Clinical observations suggest treatment-fast strain. (b)
Spirochetes may be situated where treatment is less effectual, e.g., brain. (c)
Course of conjugal syphilis suggests treatment-fast strains. (d) Granular stage
of spirochete if such exists may react to drug differently from the ordinary stage.
(e) Insufficient dosage of the drug used in the treatment of syphilis may lead to
the development of treatment-resistant cases. (f) Drug fastness induced in
vitro suggests artificial development of treatment-resistant strain. (g) Char-
acteristics of spirochetes from treatment-resistant human syphilis. Lisi recently
(1938 and 1939) (5, 6) failed in his attempt to render a strain of Spirochaeta
pallida resistant to arsenic by treating rabbits infected with this strain with
subtherapeutic doses of an arsenical. He also determined in his second study
that the administration of small doses of an arsenical before inoculation seemed
to a certain extent to inhibit the taking of syphilis and to lessen somewhat the
effectiveness of arsenical treatment given after inoculation.
THE PRESENT STUDY
Many investigators (Hoffman and Armuzzi (7), Navarro-Martin (8), Jessner
(9), Nothaas (10), Bizzozero (11), Zoon (12), Schoch and Stern (13), choch (14))
have inoculated animals with organisms from treatment-resistant patients in
attempts to determine whether resistance depends upon altered biological prop-
erties of Spirochaeta pallida; and all except Schoch (14) and one of us (H. B.)
found that strains of Spirochaeta pallida isolated from treatment-resistant human
beings were apparently not treatment-resistant in rabbits. Most of these in-
vestigations were of short duration, and unreliable criteria of treatment-resist-
ance in rabbits were used in most of them including disappearance of spirochetes
from lesions instead of the popliteal lymph node transfer method of Brown and
Pearce which we have used in our work. In 1932 an opportunity to study this
question was afforded us in the person of a patient with early syphilis whose
primary and secondary lesions remained uninfluenced by a total of 5.4 grams of
various arsenicals but whose infection was later satisfactorily controlled by the
prolonged use of bismuth salts intramuscularly and nonspecific therapy such as
intramuscular injections of boiled milk.
Two distinct problems were undertaken: (1) the characteristics of a recently
isolated strain of iSpirochaeta pallida from a patient with a treatment-resistant
syphilitic infection; and (2) the comparative effects of arsphenamine treatment
on rabbits infected with this strain and rabbits infected with Nichols-Hough
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TABLE 1
Summary of the data on rabbits inoculated with the strain of Spirocheta pallida derived
from a treatment resistant patient
ANIMAL INCUBA-RABBiTTRANSFER TION TYPE OF LESIONNUMBERNO. AND DATE PERIOD
Patient to
animals
11/7/32
1
AND DATE I
7 4256
12/12/33 4257
4258*
4259
weeks
10
5
16
11
14
3691
3692*
3693
3694
3695
3696
3697
3698
Small nodes
Normal
—
Small node
Small node
Small node
INCUBA-
TION TYPE OF LESION
PERIOD
weeks
5 Small node
5 Medium node
5 Small and
medium
node
2
1/12/33
8
2/7/34
4300
4301
4302*
4303
3744
3745
3746
3747
3748
3749*
3750
3751
3752
10
5
3
7
7
6
S
Medium node
Large chancre
Small node
Small node
Small node
Very small
node
Small node
9 4361 —
4/12/34 4362
4363
4364
5
5
—
Medium chan-
cre
Medium node
3
3/14/33
3892
3893*
8894*
3895*
4
5
10
5/23/34
Medium and
large node
Large node
11
11
4406*
4407
4408
4409
4410
4
7/25/33
Large node
Small node
11
9/7/34
3995
3996
3997
3998
4102
4103
4104
4105*
4461
4462*
4463
4464
4465
7
6
6
6
Small node
Medium node
S
5
Large node
Large node
Medium node
Small and
very large
node
12
11/2/34
5 4160
9/13/33 4161
4162*
4163
4
4
5
6
4573
4574
4575
4576
4577t
4578*
Medium node
Medium and
small node
Large and
small node
Small node
Small node
Small node
6
10/25/33
5
5
13
2/1/35
4199
4200
4201
4202 *
4743
4744
4745*
5
5
5
5
Small node
Medium node
Small node
Medium node
13A from
4577
1/4/35
4689t
4690
4691
6
5
6
Medium node
Small chancre
Small chancre
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TABLE 1—Continued
ANIMAL DI ANIMAL ABBIT INCOBA-TRANSPER RABT TION TYPE OP LESION TRANSFER UMBER TION TYPE OF LESION
NO. AND DATE NUN PERIOD NO. AND DATE N PERIOD
weeks weeks
14 4784* 4 Medium node 23 5155 n.d. Small node
4/11/35 4785 5 Medium node 10/1/36 5156 n.d. Small node
4786 5 Medium node 5157* 5 Large node
4787 6 Small node
___________ — 24 5178* 5 Large node
14A from 4762 5 Small node 11/11/36 5179 4 Chancre
4689 4763 6 Small node 5180 4 Medium node
3/1/35 4764 — ___________ ______ ______________
___________ — - 25 5207* 5 Large node
15 4805 — 1/15/37 5208 5 Chancre
6/5/35 4806* 4 Medium node 5209 5 Chancre
4807f 12 Medium node
26 5228 5 Medium node
16 4824 7 Chancre 3/10/37 5229* 5 Large node
7/25/35 4825 7 Medium node 5230 5 Large node
4826* 9 Medium node
___________ — 27 5251 4 Small node
16A from 4858 — 5/7/37 5252* 5 Large node
4807 4859 5 Chancre 5253 n.d. Small node
9/20/35 4860 5 Small node
negative 28 5281* 6 Medium node
lymph node 7/14/37 5282 n.d. Small node
transfer 5283 n.d. Small node
17 4896 — 29 5324 4 Large node
11/8/35 4897 5 Large node 10/8/37 5325 5 Medium node
4898* 5 Chancre 5326 5 Large node
5327* 5 Large node
18 4927 5 Chancre — _____________
1/7/36 4928 5 Medium node 30 5370 5 Small node
4929* 6 Chancre 12/2/37 5371 5 Small node
5372 5 Medium node
19 5009* 5 Medium node 5373* 5 Medium node
3/6/36 5010 4 Chancre
5011 5 Small node 31 5397* 4 Large node
1/26/38 5398 4 Medium node
20 5050 5 Chancre 5399 5 Medium node
4/15/36 5051 6 Small node
5052* 5 Medium node 32 5425* 4 Medium node
3/8/38 5426 4 Small node
21 5077 5 Chancre 5427 4 Small node
6/10/36 5078 5 Chancre
50 79* 5 Medium node 33 5475* 5 Large node
4/28/38 5476 4 Medium node
22 5101 4 Medium node 5477 4 Medium node
8/4/36 5102* 4 Medium node
5103 4 Medium node 34 5507 5 Medium node
5104 4 Large node 6/29/38 5508 —
5509* 5 Large node
TABLE 1—Concluded
ANIMAL
TRANSFER
NO. AND DATE
35
8/25/38
RABBIT
NUMBER
5526
5527
5528k
INCIYBA-
TION
PERIOD
weeks
4
n.d.
4
TYPE OF LESION
Medium node
Small node
Medium node
ANIMAL ABBITTRANSFER R BEENO. AND DATE NON
47 5873
4/26/40 5874
5875*
INCUBA-
TION
PERIOD
weeks
5
n.d.
5
TYPE OF LESION
Chancre
Small node
Medium node
36
10/14/38
5554*
5555
5556
5
5
4
Large node
Medium node
Large node
48
6/4/40
5907
5908
59Q9*
5
4
4
Medium node
Medium node
Large node
37
11/25/38
5586
5587*
5588
4
4
4
Medium node
Large node
Small node
49
7/26/40
5934*
5935
5936
4
4
Large node
Large node
—
38
1/11/39
5601
5602*
5603
4
4
4
Medium node
Chancre
Small node
50
9/12/40
5954
5955
5956*
4
4
5
Large node
Small node
Medium node
39
3/8/39
5629
5630
5631*
n.d.
4
4
Small node
Small node
Large node
51
10/24/40
5989*
5990
5991
4
4
4
Large node
Small node
Medium node
40
5/9/39
5660
5661
5662*
5
n.d.
4
Medium node
Small node
Medium node
52
12/23/40
6017
6018
6019*
4
4
4
Chancre
Small node
Medium node
41
6/23/39
5682
5683
5684*
4
4
5
Chancre
Chancre
Chancre
53
2/7/41
6045*
6046
6047
4
4
4
Medium node
Large node
Large node
42
8/3/39
5697*
5698
5699
5
5
5
Large node
Medium node
Medium node
54
4/4/41
6067*
6068
6069
4
4
4
Medium node
Large node
Medium node
43
10/13/39
5752
5753
5754*
n.d.
5
4
Small node
Medium node
Large node
55
5/15/41
6108
6109
6110*
4
4
4
Medium node
Medium node
Medium node
44
11/21/39
5773
5774
5775*
4
5
4
Large node
Large node
Large node
56
6/27/41
6129
6130*
6131
4
4
4
Medium node
Medium node
Small node
45
1/11/40
5783*
5784
5785
4
4
4
Medium node
Medium node
Medium node
57
9/18/41
6166
6167
6168
4
5
5
Large node
Chancre
Large node
46
3/5/40
5803
5804*
5805
4
4
4
Medium node
Large node
Small node
Rabbit numbers in italics—positive for syphilis.
* Animal used to continue strain.
t Animal used to start auxiliary strains.
Size of nodes: large node, 30 x 40 rmn.; medium node, 15 x 25 mm.; small node, 10 x
15 mm.
§ Negative on transfer.
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strain of Spirochaeta pallida. We are now reporting the results of the study of
these problems over the past nine-and-a-half years.
MATERIALS AND METHODS
Sources of the Strain of Spirochaeta pallida. In order to transfer the strain
of Spirochaeta pallida from the patient to rabbits, the patient's venous blood,
scrapings from his lip lesion, portions of the penile lesion (removed without
anesthesia), and blood from the sites of the excised portions of the penile lesion
were used as inocula. The tissue from the penile lesion was finely minced,
diluted with salt solution, and the entire suspension, divided into two parts, was
injected into the right testicles of two rabbits (3691 and 3692). The mixture
of blood and scrapings from the lip lesion was divided into two portions and in-
jected into the right testicles of two rabbits (3693 and 3694). The blood oozing
from the site of the excised portion of the penile lesion was injected into each
testicle of one rabbit (3695). Ten cc. of the patient's venous blood was diluted
with 4 cc. of normal salt solution and approximately 2 cc. of this diluted blood
was injected into each testicle of three rabbits (3696, 3697, and 3698).
Technic of carrying the strain and testing the effect of arsphenamine on rabbit
syphilis produced by this strain. After infection was transmitted from the
patient to rabbits, the strain was carried from rabbit to rabbit in the following
manner: A nodule with numerous active spirochetes, excised from the testicle
of a syphilitic rabbit, was finely minced, salt solution added, and the supernatant
fluid injected into the testicles of normal rabbits. Sometimes when the nodule
was small, the entire emulsion was used as the inoculum. When testicular
lesions appeared in the infected rabbits, certain of the animals were treated with
a standard lot8 of arsphenamine (606) intravenously. The animals were then
observed for disappearance of spirochetes and lesions for a period of three months
or more. The necessity for this prolonged observation period after treatment
was recognized by Raiziss and Severae (15) over seventeen years ago and is the
routine in this laboratory for chemotherapeutic investigation. Sterilization was
determined, not only by the return of the testicle to a normal appearance but
also by the transfer of the popliteal lymph nodes, which were removed, minced
finely, and after addition of a small amount of salt solution the resulting emulsion
was injected into the testicles of normal rabbits. If no lesions appeared in the
transfers after several months of observation, the dose of arsphenamine used
was considered sterilizing. (To confirm the sterilization of treated rabbits, in
certain cases the liver, spleen, and brain were removed, minced, and injected
intratesticularly into normal rabbits.)
RESULTS
Infectiousness of blood and lesions of the treatment-resistant syphilitic patient for
rabbits. In the original transfer of material from the treatment-resistant pa-
tient, tissue from the penile lesion, the blood oozing from the incision of this
8 Dermatological Research Laboratories, lot no. 47825. A lot of arsphenamine which
has been shown to be of rather high therapeutic activity in experimental rabbit syphilis.
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lesion, and the patient's venous blood produced syphilitic nodes with active
spirochetes in the testes of rabbits while the blood and scrapings from the lip
lesion failed to produce syphilitic infection in the rabbit.
A survey of the literature has failed to reveal another instance in which the
blood and tissues of a patient treated with so much arsenical (5.4 grams), ad-
ministered in so short a time, were infectious for rabbits.
Infectivity of the strain of Spirochaeta pallida from the treatment-resistant patient
for rabbits. Since the original transfer of the strain of Spirochaeta pallida from
the patient to rabbits, on November 17, 1932, we have to date carried the or-
ganisms through fifty-seven animal passages. During this time the strain has
developed a high grade of infectiousness for rabbits. Although the number of
positive inoculations in the first passage (from patient to rabbit) was five of
eight animals (62.5 per cent), subsequent passages up to the sixteenth gave vari-
able percentages of takes. The lowest percentage of takes occurred in the fourth
animal passage (25.0 per cent). After the sixteenth passage, nearly every
animal inoculated was infected (see Table I).
On two occasions the strain was almost lost. In the third animal passage,
the testicular node of rabbit 3894 transferred to four normal rabbits failed to
produce syphilitic lesions. In the effort to recover the strain the following pro-
cedures were used: the emulsion of the popliteal lymph nodes and small syphi-
litic testicular node of one rabbit (3892) and the popliteal lymph node of another
rabbit (3894) was injected into two normal rabbits (4102 and 4103) which failed
to become infected. At the same time, the emulsion of popliteal lymph nodes
and repeatedly darkfield negative small testicular indurations of another rabbit
(3893) and the popliteal node of a fourth rabbit (3895) produced positive inocu-
lations in their transfers (4104 and 4105). Another occasion of low infectivity
of the strain occurred in the twelfth animal passage, when only one-third of the
rabbits (two of six) inoculated were infected. In view of the high infectivity
which has developed in this strain of Spirochaeta pallida, no further difficulty
was experienced in its maintenance for nine-and-a-half years.
Coincident with the increased infectivity of this strain for rabbits, there has
apparently been an increase in the number of spirochetes in a given lesion and
the organisms themselves seem to have become more robust and active.
Incubation period of this strain of Spirochaeta pallida. The incubation period
(time from inoculation to first appearance of syphilitic lesions) varied in the
initial passage from the patient to animals from 5 to 16 weeks (5, 10, 11, 14, and
16 weeks for the 5 rabbits respectively). For the first 28 animal passages the
average incubation period for this strain fluctuated between 4 and 11 weeks,
but for the remaining passages, the average incubation period for each animal
passage was between 4 and 5 weeks. The average for all the animal
passages was 4.65 weeks. In the more recent passages, 29 to 57 inclusive, the
average was 4.24 weeks. The incubation period of this strain has now become
about the same as that for the standard laboratory Nichols4lough strain as
determined in this laboratory (4 to 6 weeks).
Types of lesions produced by this strain of ,Spirochaeta pallida. In the beginning
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of our study, the strain produced variously sized, frequently barely palpable,
hard nodules in the rabbit testicle. It was oniy after darkflêld examination of
aspirated fluid revealed numerous active organisms that the syphilitic nature
of these lesions was accepted. Often, although the lesions were small, they
contained a large number of actively motile spirochetes. The spontaneous
involution of the lesions in untreated animals seemed unusually rapid. While
the usual lesion was an inconspicuous nodule, an occasional large rabbit chancre
was produced (rabbit 4303). As the number of transfers increased, the lesions
produced by this strain of Spirochaeta pallida gradually assumed the more
usual characteristics of those produced by the Nichols-Hough strain. Chancres
were more frequent and the nodes were usually medium or large (Table I).
In the beginning of our study, this strain, infective for rabbits in spite of its
derivation from a treated patient, had the property of producing inconspicuous,
low-grade tissue reactions, with a tendency to rapid spontaneous involution and
occasionally a tendency to produce asymptomatic infection. As the spirochete
was passed from rabbit to rabbit, it apparently became adapted to its new host
and tended to assume the more usual characteristics of the Nichols-Hough
standard laboratory strain with the production of large nodules and chancres
and no further asymptomatic infections. The organism became so infective for
rabbits that after the sixteenth animal passage, nearly every rabbit inoculated
became syphilitic.
Effect of arsphenamine injected intravenously on syphilis produced by this strain.
In order to test the effect of arsphenamine injected intravenously on the lesions
produced by this strain of Spirochaeta pallida, we treated two groups of syphilitic
rabbits with various doses of a standard lot of arsphenamine (606) (Dermatologi-
cal Research Laboratories no. 47825). (Because of scarcity of the standard lot
of arsphenamine, a few rabbits were treated with another lot of potent arsphena-
mine (606).) One group, control, was infected with the Nichols-Hough strain;
the other was infected with the strain under investigation. In this laboratory
over a period of fifteen years or more, the minimal sterilizing dose of this standard
arsphenamine (47825) used in rabbits infected with the Nichols-Hough strain
has been fourteen milligrams per kilogram of body weight. Table II shows that
with the new strain, this same drug failed to sterilize 13 of 51 rabbits treated
with doses of from 14 to 30 mgm. per kilogram of body weight. Of these 13
rabbits which failed to be sterilized, four were treated with 14 mgm. per kilogram
(one of these was treated with other than the standard lot of arsphenamine);
5 with 16 mgm. per kilogram; one with 18 mgm. per kilogram; one with 20 mgm.
per kilogram; and two with 25 mgm. per kilogram.
While the proportion of failure to sterilize seems fairly high (25.5 per cent),
the results reviewed in the light of the course of the study indicate that there
has been a definite lessening of the treatment refractoriness of this strain. In
the early years of this study the refractoriness to treatment was manifested
against doses as high as twenty-five milligrams per kilogram of body weight.
After June, 1036, no rabbit was resistant to treatment with doses of arsphena-
mine of 20 to 30 mgm. per kilogram of body weight. Accordingly, smaller
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TABLE II
Effects of treatment with arsphenamine 47825 intravenously of syphilitic rabbits inoculated with
a strain of iS!pirocheta pallida isolated from a treatment-resistant case of human syphilis
DARK-FIELD
DOSE DARE-FIELD AFTER TESTI-
PER LESIONS BEFORE TREATMENT BEFORE TREATMENT CLE POPLIN-
B KILO- TREATMENT NEGATIVE NOR- EAL DATE OF DATE OF
GRAM IN MAL NODE
- TREAT- TRANS.
z Or _____________
_____________ _________ __________ AFTER TRAIlS- WENT PERi BODY . TREAT- PERRight LeftWEIGHT Right testicle Left testicle testi- testi- Hours Days WENT
dc dc
days
3691 0.025 Small node Normal +4 Neg. 24 7 Neg. 2/ 1/33 3/28/33
3692 0.020 Normal Normal Neg. 1/20/33 6/ 1/33
3695 0.016 Induration Small node Neg. +4 4 16 Neg. 3/13/33 6/30/33
3697 0.018 Small node Small node +1 24 51 Neg. 3/13/33 7/25/33
3698 0.016 Small node Small node +4 +4 5 16 Neg. 3/13/33 7/28/33
3749 0.018 Very small node Very small node +i +1 2 7 +4 4/ 5/33 10/27/33
3748 0.016 Node removed Small node +1 24 7 Neg. 4/ 5/33 7/28/33
3752 0.016 Small node Induration +4 24 5 +4 3/24/33 7/28/33
4104 0.016 Small node and Medium node +4 +4 2 15 Neg. 10/ 3/33 1/ 5/34
chancre and small
chancre
4105 0.014 Node removed Medium hard +4 +4 7 15 +4 10/ 3/33 1/ 5/34
node
4129 0.016 Medium hard Normal +4 6 24 +4 11/23/33 2/21/34
node
4160 0.018 Medium hard Medium node +2 +4 2 13 Neg. 10/25/33 2/21/34
node
4161 0.016 Medium hard Small node +4 +4 2 21 Neg. 10/25/33 2/21/34
node
4163 0.016 Small node Small node +4 +4 24 7 Neg. 10/25/33 2/21/34
4201 0.016 Small node Medium hard +4 24 15 Neg. 1/ 4/34 4/26/34
node
4204 0.018 Small node Small node § 24 34 Neg. 1/29/34 7/24/34
4257 0.020 Small node Small node +4 +4 24 13 Neg. 2/13/34 7/24/34
4286 0.018 Small node Medium node 13 Neg. 3/22/34 7/24/34
4302 0.018 Normal Normal Neg. 4/24/34 7/24/34
4303 0.018 Chancre; small Medium chancre; +4 § 24 35 Neg. 4/ 5/34 7/24/34
in duration medium node
4364 0.016 Removed Induration +4 5/23/34 10/12/34
4406 0.025 Removed Normal Neg. 7/ 2/34 12/25/34
4408 0.025 Medium node Normal +4 4 13 Neg. 9/20/34 12/28/34
4461 0.025 Large hard node +4 7 16 Neg. 11/19/34 2/14/35
4462 0.025 Large node +4 7 15 Neg. 11/ 6/34 2/14/38
4464 0.025 Medium hard Medium hard +4 +4 24 9 Neg. 11/19/34 2/14/35
node node
4465 0.025 Small node Very large node +4 +4 3 35 Neg. 11/ 6/34 2/14/35
4824 0.025 Medium hard Medium node +4 +4 6 19 +4 10/15/35 1/31/36
node and chancre
4859 0.025 Large node Large node and +4 +4 8 37 Neg. 11/ 4/15 3/13/36
chancre
4897 0.025 Large chancre Large chancre +4 +4 24 29 Neg. 1/ 8/36 4/15/36
and node and node
4940 0.025 Large edema Medium node +4 +4 24 21 Neg. 4/ 2/36 8/ 4/16
4927 0.020 Medium node Medium hard +4 +4 24 28 Neg. 4/ 2/38 8/ 4/36
and small chancre
chancre
5011 0.025 Small hard node Small node +4 +4 2 16 Neg. 5/12/36 10/ 2/36
chancre
5010 0.020 Small hard node Small hard node +4 +4 2 9 +4 5/12/36 9/24/36
5050 0.025 Medium hard Large node and +4 +4 2 24 +4 6/23/36 10/ 2/36
node small chancre
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TABLE Il—Continued
N
z
DOSE
PER
KILO
ORAM
OF
BODY
WEIGHT
LESIONS BEFORE TREATSIINT
DARE-FIELD
BEFORE
TREATMENT
DARK-FIELD
AFTER
TREATMENTBC
IN
CLE
NOR-
HAL
AFTER
TREAT-
MENT
FOLlY-
EAL
NODE
TRA5S-
PER
DATE OF
TREAT-
KENT
DATE OP
TRAjS-
PER
Right testicle Left testicle
Ri ht
testi-dc
Left
testi-dc Hours Days
5078
5154
5159
0.025
0.020
0.025
Medium hard
node
Large hard node
Medium hard
node
Medium hard
node
Largehard node
Medium hard
node
+4
+4
+4
+4
+4
+4
24
24
2
days
21
15
15
Neg.
Neg.
Neg.
10/ 6/36
11/24/36
11/24/38
1/27/37
6/25/37
6/25/37
5179
5180*
0.014
0.014
Medium hard
node
Small node
Small node
Large node and
chancre
+4
+4
+4
+4
24
24
16
30
22
15
28
21
21
14
21
21
15
15
8
Neg.
+4
Neg.
Neg.
Neg.
Neg.
Neg.
+4
+4
+4
Neg. 10
wks.
+4
Neg.
1/18/37
1/18/37
10/18/38
10/18/38
1/29/40
1/29/40
3/ 3/41
3/ 3/41
4/ 7/41
4/ 7/41
5/20/41
5/20/41
5/20/41
6/25/37
6/30/37
4/12/39
4/12/38
7/26/40
10/ 9/40
6/11/41
6/11/41
8/ 6/41
8/ 6/41
10/ 3/41
5526
5528
8774f
5775
6017
6019
6047
6046
6067
6068
6069
0.025
0.030
0.025
0.025
0.016
0.014
0.014
0.016
0.016
0.016
0.014
Medium node
and chancre
Removed
Very large hard
node and
chancre
Removed
Large chancre
and node
Medium node
and chancre
Large node and
chancre
Very large chan-
ore and node
Removed
Medium hard
node
Large hard node
Medium node
and chancre
Large hard node
Large hard node
and chancre
Large hard node
and medium
chancre
Large chancre
and node
Medium node
and chancre
Large node and
chancre
Very largechan-
crc and node
Medium hard
node
Medium hard
node and
small chancre
Large hard node
+4
+4
+4
+4
+4
+4
+4
+4
+4
+4
+4
+4
+4
+4
+4
+4
+4
+4
+4
+4
24
24
24
24
24
24
6
2
2
2
3
• 5179 and 5180: These rabbits were not treated with Index Arsphenamine. An ordinary arsphenamine 610836
was used.
t 5774: This rabbit had a very unusually large lesion.
Few quite motile.
§ Few spirochetes.
doses were again tried, and in 1941 four rabbits were found, one in the fifty
second and two in the fifty-third animal transfer and one in the fifty-fourth
transfer, which were not cured by 14 and 16 mgm. of arsphenamine per kilogram
of body weight.
Early in the course of the study, two chains of treatment-resistant syphilis
were found (fig. 1). Rabbit 3692, infected directly from the patient, responded
to treatment. Rabbits 3749 and 3752, infected from rabbit 3692, were however,
refractory to therapy. Rabbit 4204, whose infection came from treatment-
resistant rabbit 3749, was "cured" by treatment; but rabbit 4129, infected with
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spirochetes from rabbit 3752, failed to be "cured." No further example of this
chain of infections occurred until the fifty-second transfer (fig. 2) when rabbit
6019 failed to be "cured" by only fourteen milligrams of arsphenamine per kilo-
gram of body weight; and rabbits 6046 and 6047 in the fifty-third transfer in-
fected with spirochetes from rabbit 6019 failed to be "cured" by sixteen and
fourteen milligrams of arsphenamine per kilogram of body weight respectively.
Rabbit 6045 into which the strain was passed, was not treated but rabbit 6068
Patient
Rabbit 3692 (-)
abbit+) t 3752 ()
Rabbit04 (-) Rabb4l29 (4)
(—) "cured"
(+) failed to become
"cured"
FIG. 1
Rabbit 5989 (not treated)
Rebblt 6017 (-) Rabbit 6018 (not treated) Rabbit 6019 (..)
Rabbit 6045 (not treated) Rabbit 6046 (4) Rabbit 6047 (4.)
Rabbit 6067 (—) Rabbit 6068 (÷) Rabbit 6069 (—)
FIG.2
whose infection was derived from rabbit 6045 was not "cured" by 16 milligrams
of arsphenamine per kilogram of body weight.
These treatment results in general would tend to indicate that a strain of
spirochetes has been found which throughout its existence in rabbits has sporadi-
cally exhibited evidences of refractoriness to treatment, but whose refractoriness
has become quantitatively less as the strain has become more adapted to its
new host. This quantitative change is indicated by the increasing difficulty in
recent years of finding infected rabbits whose syphilis resisted treatment signif-
icantly higher than the usual sterilizing dose of a potent arsphenamine.
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These studies indicate, however, that there is no regularity in the occurrence
of treatment refractoriness in rabbit syphilis in spite of suggestive chains of
treatment-resistant cases. This observation may account for the unpredictable
way in which treatment-resistance affects one or both parties in conjugal syphilis
presumably caused by the same strain of Spirochaeta pallida.
SUMMARY AND CONCLUSIONS
The problem of the cause of treatment-resistant syphilis is still in a state of
flux. There is much evidence suggesting the importance of either the host, the
drug or the spirochete, or a combination of these in the production of this state.
In 1932, an opportunity to study the role of Spirochaeta pallida presented it-
self in a patient with treatment-resistant syphilis whose infection failed to re-
spond to 5.4 grams of various arsenicals, but did respond to injections of bismuth
compounds and non-specific therapy (mild). The present report details the
results of a nine-and-a-half year study of the biologic properties and the response
to arsenical treatment of this strain of Spirochaeta pallida as observed in rabbits
infected with it.
It was difficult at first to get a high percentage of takes in rabbits with this
strain, hut as the number of transfers increased it was found that from the
sixteenth to the fifty-seventh animal passage, nearly every rabbit inoculated
was infected.
The incubation period at first variable and in cases prolonged (sixteen weeks
in one case), settled down after the strain, became adapted to the host to a final
average of about four weeks. This is approximately the same as the incubation
period of the standard laboratory strain (Nichols-Hough strain).
In the beginning, this strain produced variously sized, frequently barely
palpable, hard syphilitic nodules in the rabbit testicle. Occasionally a typical
rabbit chancre was produced. As the number of transfers increased, the lesions
tended to assume the more usual characteristics of those produced by the
Nichols-Hough strain.
The experiments to determine the therapeutic response of this strain to
arsphenamine were controlled by the use of the Nichols-Hough strain of Spiro-
chaeta pallida, and by the use of a standard lot of the drug, the minimal steriliz-
ing dose of which over more than ten years had been 14 mgm. per kilogram of
body weight. It was found that 13 of 51 rabbits treated with doses of from 14
to 30 mgm. per kilogram of body weight failed to be "cured." (Four were
treated with 14 mgm. per kilogram; 5 with 16 mgm.; one with 18 mgm.; one
with 20 mgm., and two with 25 mgm.).
This treatment refractoriness was'sporadic, since it was more pronounced in
the beginning of the study and occurred less frequently as the strain became
adapted to the new host. Three chains of treatment refractoriness were ob-
served, two early in the study and one recently.
We have demonstrated that Spiroehaeta pallida derived from a treatment
refractory patient may retain a certain amount of this characteristic resistance
to treatment when the strain has been carried through many animal passages.
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DISCUSSION
Da. JosEPH V. KLAUDER, Philadelphia: I think Dr. Beerman has gone further than other
investigators, including myself, who have attempted to show arsenic resistant strain.
Other investigators have shown that there exists evidence of arsenic resistance up to a cer-
tain point, and when that point in dosage is exceeded there is no evidence of resistance.
Dr. Beerman has started with a strain in which it was clinically demonstrated that there
vas no resistance to arsenic. In their investigations a dosage of 14 mgm. per kilogram,
which is the standard curative dose of arsphenamine in syphilis, was exceeded. It is extra-
ordinary that these investigators have carried the dosage to 25 mgm. per kilogram with no
evidence of cure in the infected rabbits. This paper shows that several factors are to be
coisidered, an arsenic resistant strain of organism, as well as the state of the host.
DR. MARIE SEvREAc, Philadelphia: There is one important point to be considered in the
transfer of the infected material from patient to rabbit. Since rabbits and mice are very
susceptible to secondary infection, and if the area of transfer from the skin of the patient
to the rabbit is not sterilized, the result will be disappointing, because most of the rabbits
develop very large abscesses in the testicles, or if mice are used they usually die from septi.
cemia. On the other hand, if one sterilizes too much, one is apt to destroy the spirochetes.
Accordingly one must find the medium between these two extremes.
Another important point to bear in mind in making the transfer is to be very careful to
examine each small induration that is produced in the rabbit's testicle, since missing one
small induration might cause the loss of the strain.
If these two technical points are kept in mind it will aid in obtaining successful results.
DR. GEORGE W. RAIZISS, Philadelphia: I would like to congratulate Doctors Beerman
and Severac upon their presentation, which throws light on the possibility of certain strains
of Spirochaeta pallida being more resistant to treatment in experimental rabbit syphilis
than an ordinary strain would be.
It must be noted that the transfer of the popliteal node, which is the final criterion for
cure, was made three months or more after administration of the drug. This is rather es-
sential, because some investigators were satisfied with the transfer of the popliteal nodes
six weeks after the administration of the arsphenamine. Many errors have been made in
this way in the appraisal of the value of the drug.
Another essential note is that Doctors Beerman and Severac were working with one
definite lot number of arsphenamine, the lot number that we kept for many years in our
laboratories, the minimal sterilizing dose of which is 14 mgm. per kilogram of body weight.
If they had changed the lot numbers they might conceivably have bad some errors in their
investigations. It should also be noted that the ave,rage lots of arsphenamine have a steri.
using dose of 18 mgm. In rabbit syphilis certain lots of drugs give precise effect at definite
doses. In other words, we have here a biological precision which is unusual.
The conclusions which Doctors Beerman and Severac have arrived at are substantiated
by the fact that they used one definite lot of arsphenamine with a sterilizing dose of 14
mgm. per kilo in their experimental rabbit syphilis investigation, whereas, they found
resistance in certain of the rabbits, infected with their strain, to doses up to 25 mgm. per
kilo of body weight. Therefore, in my opinion, it indicates a definite treatment-resistant
quality of this strain.
Dn. HERMAN BEERMAN, Philadelphia: I have nothing to add but to thank the discussors
for agreeing with us.
